Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experience.
Ghalehtaki R, Kolahdouzan K, Piozzi GN, Rezaei S, Shaka Z, Darzikolaee NM, Bayani R, Behboudi B, Aghili M, Couñago F, Sharifian A, Bagheri F, Nazari R, Nabian N, Babaei M, Tafti MA, Fazeli M, Farhan F. Ghalehtaki R, et al. Radiat Oncol J. 2024 Dec;42(4):273-280. doi: 10.3857/roj.2024.00136. Epub 2024 Sep 19. Radiat Oncol J. 2024. PMID: 39748528 Free PMC article.
Surface mold brachytherapy for head and neck non-melanoma skin cancer - local control rates and survival: A retrospective analysis.
Esmati E, Abyaneh R, Jaberi R, Naderinasab S, Gholami S, Payandeh M, Salarvand F, Khalilian A, Seiri M, Lashkari M, Babaei M, Aghili M, Kazemian A, Kamrava M, Ghalehtaki R. Esmati E, et al. Among authors: ghalehtaki r. J Contemp Brachytherapy. 2024 Oct;16(5):323-334. doi: 10.5114/jcb.2024.144703. Epub 2024 Oct 28. J Contemp Brachytherapy. 2024. PMID: 39719956 Free PMC article.
Outcomes of definitive radiotherapy vs. laryngectomy followed by adjuvant radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma: real-world experience in a referral cancer center.
Kazemian A, Esmati E, Ghalehtaki R, Farazmand B, Mousavi-Darzikolaee N, Bayani R, Razmkhah M, Taherioun M, Saeedi N, Heidari F, Zakeri K. Kazemian A, et al. Among authors: ghalehtaki r. Radiat Oncol. 2024 Dec 18;19(1):180. doi: 10.1186/s13014-024-02565-9. Radiat Oncol. 2024. PMID: 39696417 Free PMC article.
Postoperative NEOadjuvant TEMozolomide followed by chemoradiotherapy versus upfront chemoradiotherapy for glioblastoma multiforme (NEOTEM) trial: Interim results.
Sharifian A, Kazemian A, Farzin M, Amirkhani N, Farazmand B, Naderi S, Khalilian A, Pourrashidi A, Amjad G, Kolahdouzan K, Abyaneh R, Jablonska PA, Ghalehtaki R. Sharifian A, et al. Among authors: ghalehtaki r. Neurooncol Adv. 2024 Nov 14;6(1):vdae195. doi: 10.1093/noajnl/vdae195. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39664679 Free PMC article.
Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis.
Azimi A, Tabatabaei FS, Kolahdouzan K, Rashidian H, Nourbakhsh F, Parizi MA, Darzikolaee NM, Bayani R, Salarvand S, Sharifian A, Bagheri F, Rezaei S, Nabian N, Nazari R, Mohammadi N, Babaei M, Lashkari M, Farhan F, Aghili M, Couñago F, Gambacorta MA, Ghalehtaki R. Azimi A, et al. Among authors: ghalehtaki r. Radiat Oncol. 2024 Dec 3;19(1):172. doi: 10.1186/s13014-024-02562-y. Radiat Oncol. 2024. PMID: 39627803 Free PMC article.
52 results